Provided by Tiger Trade Technology Pte. Ltd.

Fate Therapeutics

2.38
-0.0550-2.26%
Volume:198.37K
Turnover:474.08K
Market Cap:285.00M
PE:-2.26
High:2.44
Open:2.41
Low:2.37
Close:2.43
52wk High:3.23
52wk Low:0.9335
Shares:120.00M
Float Shares:104.94M
Volume Ratio:0.28
T/O Rate:0.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0528
EPS(LYR):-1.1500
ROE:-60.75%
ROA:-26.22%
PB:1.86
PE(LYR):-2.07

Loading ...

Aug 14, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 13, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 13, 2026

Major Issues Report

Form 8-K - Current report
Aug 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 08, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jun 15, 2026

Major Issues Report

Form 8-K - Current report
Jun 05, 2026

Major Issues Report

Form 8-K - Current report
May 20, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 20, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 13, 2026

Major Issues Report

Form 8-K - Current report
May 13, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 26, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 26, 2026

Major Issues Report

Form 8-K - Current report
Jan 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2025

Major Issues Report

Form 8-K - Current report
Nov 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 27, 2025

Major Issues Report

Form 8-K - Current report